Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
Researchers discover antibiotic that could prevent diarrhea caused by C. difficile

Researchers discover antibiotic that could prevent diarrhea caused by C. difficile

Removing bacterial armor could be new way to fight anthrax

Removing bacterial armor could be new way to fight anthrax

Lawmakers united against high drug prices bare partisan teeth

Lawmakers united against high drug prices bare partisan teeth

Researchers uncover possibility of acoustic side-channel attack on DNA synthesis process

Researchers uncover possibility of acoustic side-channel attack on DNA synthesis process

Lab instruments may leak valuable information, finds study

Lab instruments may leak valuable information, finds study

Growth of genomic databases hinders efforts to identify bacteria

Growth of genomic databases hinders efforts to identify bacteria

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

Innovative strategy opens up new avenue of treatment for anthrax infections

Innovative strategy opens up new avenue of treatment for anthrax infections

Scientists develop dual anthrax-plague vaccine

Scientists develop dual anthrax-plague vaccine

Researchers provide new virulence clues through genomic study of anthrax strains

Researchers provide new virulence clues through genomic study of anthrax strains

Scientists decipher workings of little-understood bacterial riboswitch

Scientists decipher workings of little-understood bacterial riboswitch

Computer-based models reveal optimal conditions for killing harmful bacteria

Computer-based models reveal optimal conditions for killing harmful bacteria

Two studies set groundwork for new avenues to treat influenza and anthrax poisoning

Two studies set groundwork for new avenues to treat influenza and anthrax poisoning

Molecular map shows novel way to stop dangerous bioweapon

Molecular map shows novel way to stop dangerous bioweapon

Study shows how climate change affects Europe's most dangerous pathogens

Study shows how climate change affects Europe's most dangerous pathogens

Zika: costs of prevention and control

Zika: costs of prevention and control

TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin

TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Research finding could set stage for potential development of new antimicrobial drugs

Research finding could set stage for potential development of new antimicrobial drugs

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs